{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:42:27Z","timestamp":1781815347534,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,12,8]],"date-time":"2008-12-08T00:00:00Z","timestamp":1228694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s11940-009-0008-6","type":"journal-article","created":{"date-parts":[[2008,12,7]],"date-time":"2008-12-07T04:10:00Z","timestamp":1228623000000},"page":"55-63","source":"Crossref","is-referenced-by-count":10,"title":["Acute demyelinating disorders of the central nervous system"],"prefix":"10.1007","volume":"11","author":[{"given":"Meghan K.","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hadi","family":"Maghzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Etemadifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger E.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Gonzalez-Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Minagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,8]]},"reference":[{"key":"8_CR1","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","volume":"354","author":"E.M. Frohman","year":"2006","unstructured":"Frohman EM, Racke MK, Raine CS: Multiple sclerosis\u2014the plaque and its pathogenesis. N Engl J Med 2006, 354:942\u2013955.","journal-title":"N Engl J Med"},{"key":"8_CR2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0887-8994(00)00229-0","volume":"24","author":"R. Straussberg","year":"2001","unstructured":"Straussberg R, Schonfeld T, Weitz R, et al.: Improvement of atypical acute disseminated encephalomyelitis with steroids and intravenous immunoglobulins. Pediatr Neurol 2001, 24:139\u2013143.","journal-title":"Pediatr Neurol"},{"key":"8_CR3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/01.wnl.0000318281.98220.6f","volume":"71","author":"F. Fazekas","year":"2008","unstructured":"Fazekas F, Lublin FD, Li D, et al.: Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Neurology 2008, 71:265\u2013271.","journal-title":"Neurology"},{"key":"8_CR4","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1212\/WNL.52.9.1737","volume":"52","author":"D.S. Goodin","year":"2002","unstructured":"Goodin DS, Frohman EM, Garmany GP, et al.: Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2002, 52:1737\u20131745.","journal-title":"Neurology"},{"key":"8_CR5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.WNL.0000138572.82125.F5","volume":"63","author":"S.A. Morrow","year":"2004","unstructured":"Morrow SA, Stoian CA, Dmitrovic J, et al.: The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis. Neurology 2004, 63:1079\u20131080.","journal-title":"Neurology"},{"key":"8_CR6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"R.W. Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr, et al.: A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992, 326:581\u2013588.","journal-title":"N Engl J Med"},{"key":"8_CR7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.39.9.1143","volume":"39","author":"H.L. Weiner","year":"1989","unstructured":"Weiner HL, Dau PC, Khatri BO, et al.: Double blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology 1989, 39:1143\u20131149.","journal-title":"Neurology"},{"key":"8_CR8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1212\/WNL.43.6.1100","volume":"43","author":"M. Rodriguez","year":"1993","unstructured":"Rodriguez M, Karnes WE, Bartleson JD, et al.: Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology 1993, 43:1100\u20131104.","journal-title":"Neurology"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000008030","volume":"41","author":"P. Jacquerye","year":"1999","unstructured":"Jacquerye P, Osseman H, Laloux P, et al.: Acute fulminant multiple sclerosis and plasma exchange. Eur Neurol 1999, 41:174\u2013175.","journal-title":"Eur Neurol"},{"key":"8_CR10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0404.2008.01002.x","volume":"118","author":"A. Argyriou","year":"2008","unstructured":"Argyriou A, Makris N: Neuromyelitis optica: a distinct demyelinating disease of the central nervous system. Acta Neurol Scand 2008, 118:209\u2013217.","journal-title":"Acta Neurol Scand"},{"key":"8_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","volume":"58","author":"M. Keegan","year":"2002","unstructured":"Keegan M, Pineda AA, McClelland RL, et al.: Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002, 58:143\u2013146.","journal-title":"Neurology"},{"key":"8_CR12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11940-008-0007-z","volume":"10","author":"D.M. Wingerchuk","year":"2008","unstructured":"Wingerchuk DM, Weinshenker BG: Neuromyelitis optica. Curr Treat Options Neurol 2008, 10:55\u201366.","journal-title":"Curr Treat Options Neurol"},{"key":"8_CR13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1352458506071174","volume":"13","author":"S. Watanabe","year":"2007","unstructured":"Watanabe S, Nakashima I, Misu T, et al.: Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007, 13:128\u2013132.","journal-title":"Mult Scler"},{"key":"8_CR14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/08830738020170111001","volume":"17","author":"E. Shahar","year":"2002","unstructured":"Shahar E, Andraus J, Savitzki D, et al.: Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulin. J Child Neurol 2002, 17:810\u2013814.","journal-title":"J Child Neurol"},{"key":"8_CR15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1212\/WNL.59.8.1224","volume":"59","author":"S. Tenembaum","year":"2002","unstructured":"Tenembaum S, Chamoles N, Fejerman N: Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2002, 59:1224\u20131231.","journal-title":"Neurology"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0887-8994(99)00042-9","volume":"21","author":"M. Nishikawa","year":"1999","unstructured":"Nishikawa M, Ichiyama T, Hayashi T, et al.: Intravenous immunoglobulin therapy in acute disseminated encephalomyeleitis. Pediatr Neurol 1999, 21:583\u2013586.","journal-title":"Pediatr Neurol"},{"key":"8_CR17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/PL00007836","volume":"249","author":"E. Marchioni","year":"2002","unstructured":"Marchioni E, Marinou-Aktipi K, Uggetti C, et al.: Effectiveness of intravenous immunoglobulin in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol 2002, 249:100\u2013104.","journal-title":"J Neurol"},{"key":"8_CR18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jca.20022","volume":"19","author":"C.H. Lin","year":"2004","unstructured":"Lin CH, Jeng JS, Yip PK: Plasmapheresis in acute disseminated encephalomyelitis. J Clin Apher 2004, 19:154\u2013159.","journal-title":"J Clin Apher"},{"key":"8_CR19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/088307389501000612","volume":"10","author":"M. Kleiman","year":"1995","unstructured":"Kleiman M, Brunquell P: Acute disseminated encephalomyelitis: response to intravenous immunoglobulin. J Child Neurol 1995, 10:481\u2013483.","journal-title":"J Child Neurol"},{"key":"8_CR20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-510X(99)00072-6","volume":"165","author":"S. Pradhan","year":"1999","unstructured":"Pradhan S, Gupta RP, Shashank S: Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci 1999, 165:56\u201361.","journal-title":"J Neurol Sci"},{"key":"8_CR21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1212\/WNL.54.6.1370","volume":"54","author":"D.J. Sahlas","year":"2000","unstructured":"Sahlas DJ, Miller SP, Guerin M: Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 2000, 54:1370\u20131372.","journal-title":"Neurology"},{"issue":"2Suppl1","key":"8_CR22","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.tmrv.2007.01.002","volume":"21","author":"T. Feasby","year":"2007","unstructured":"Feasby T: Guidelines on the use of intravenous immune globulin for neurologic conditions. Transfus Med Rev 2007, 21(2 Suppl 1):S57\u2013S107.","journal-title":"Transfus Med Rev"},{"key":"8_CR23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/jca.20103","volume":"21","author":"R. Lu","year":"2006","unstructured":"Lu R, Keilson G: Combination regimen of methylprednisolone, IV immunoglobulin and plasmapheresis early in the treatment of acute disseminated encephalomyelitis. J Clin Apher 2006, 21:260\u2013265.","journal-title":"J Clin Apher"},{"key":"8_CR24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0022-510X(92)90264-L","volume":"113","author":"S.M. Deckert","year":"1992","unstructured":"Deckert SM, Schlluter D, Schwendemann G: Evaluation of IL-2, sIL2R, IL-6, TNF-alpha, and IL-1 beta levels in serum and CSF of patients with optic neuritis. J Neurol Sci 1992, 113:50\u201354.","journal-title":"J Neurol Sci"},{"key":"8_CR25","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/WNL.56.11.1514","volume":"56","author":"J.H. Noseworthy","year":"2001","unstructured":"Noseworthy JH, O\u2019Brien PC, Petterson TM, et al.: A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. Neurology 2001, 56:1514\u20131522.","journal-title":"Neurology"},{"key":"8_CR26","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1212\/01.WNL.0000152873.82631.B3","volume":"64","author":"H.G. Roed","year":"2005","unstructured":"Roed HG, Langklide A, Sellebjberg F, et al.: A double-blind randomized trial of IV immunoglobulin treatment in acute optic neuritis. Neurology 2005, 64:804\u2013810.","journal-title":"Neurology"},{"key":"8_CR27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jnnp.71.2.272","volume":"71","author":"P. Defresne","year":"2001","unstructured":"Defresne P, Meyer L, Tardieu M, et al.: Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J Neurol Neurosurg Psychiatry 2001, 71:272\u2013274.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8_CR28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0887-8994(98)00065-4","volume":"19","author":"E. Lahat","year":"1998","unstructured":"Lahat E, Pillar G, Ravid S, et al.: Rapid recovery from transverse myelopathy in children treated with methylprednisolone. Pediatr Neurol 1998, 19:279\u2013282.","journal-title":"Pediatr Neurol"},{"key":"8_CR29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.sc.3101190","volume":"39","author":"J. Kalita","year":"2001","unstructured":"Kalita J, Misra UK: Is methylprednisolone useful in acute transverse myelitis? Spinal Cord 2001, 39:471\u2013476.","journal-title":"Spinal Cord"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-009-0008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-009-0008-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-009-0008-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:53Z","timestamp":1559422613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-009-0008-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1007\/s11940-009-0008-6","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,8]]}}}